Markers of bone remodeling: general concepts and clinical significance for skeletal lesions in oncologic patients
Liubimova, N.V.; Kushlinskiĭ, N.E.
Voprosy Onkologii 47(1): 18-33
2001
ISSN/ISBN: 0507-3758 PMID: 11317531 Document Number: 539533
Document emailed within 1 workday
Related Documents
Peng, F.; Fu, R.; Liu, H.; Wang, Y.; Ding, K.; Ding, S.; Liu, Z.; Ruan, E.; Qu, W.; Wang, H.; Xing, L.; Wang, X.; Wang, G.; Song, J.; Wu, Y.; Li, L.; Liu, H.; Guan, J.; Shao, Z. 2015: Clinical significance of serum bone metabolic markers in diagnosis and monitoring of myeloma bone disease Zhonghua Yi Xue Za Zhi 95(42): 3436-3439Rico, H.; Revilla, M.; Arnanz, F.; Villa, L.F.; Perera, S.; Arribas, I. 1993: Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis Obstetrics and Gynecology 81(2): 272-275
Jarava, C.; Armas, J.R.; Palma, A. 2000: Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 20(4): 362-372
Riesco, M.; Sastre, P.; Barceló, A.; Pérez, G. 1999: Biochemical markers of bone remodeling. Apropos of osteoporosis screening Medicina Clinica 112(1): 39
Pectasides, D.; Nikolaou, M.; Farmakis, D.; Kanakis, I.; Gaglia, A.; Kountourakis, P.; Karamanos, N.K.; Economopoulos, T.; Raptis, S.A. 2005: Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid Anticancer Research 25(2b): 1457-1463
Montano-Loza, A.J. 2013: New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients Minerva Gastroenterologica E Dietologica 59(2): 173-186
Kurokouchi, K.; Ito, T.; Ohmori, S.; Kanda, K.; Murata, Y.; Seo, H. 1995: Changes in the markers of bone metabolism following skeletal unloading Environmental Medicine: Annual Report of the Research Institute of Environmental Medicine Nagoya University 39(1): 21-24
Yamauchi, M. 2009: Biochemical markers of bone turnover. new aspect. Biochemical bone markers of bone in patients treated with glucocorticoid Clinical Calcium 19(8): 1092-1100
Hamakawa, H.; Takemura, M.; Sato, M.; Shinohe, R.; Koishi, H.; Furuta, N.; Ohta, H.; Koike, N.; Iwamoto, N.; Yamada, Y.; Wada, H.; Saito, K.; Seishima, M. 2003: Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other inflammatory markers(IL-6, IL-8) Rinsho Byori. Japanese Journal of Clinical Pathology 51(1): 13-18
Hamakawa, H.; Takemura, M.; Sato, M.; Shinohe, R.; Koishi, H.; Furuta, N.; Ohta, H.; Koike, N.; Iwamoto, N.; Yamada, Y.; Wada, H.; Saito, K.; Seishima, M. 2003: Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other inflammatory markers(IL-6, IL-8) Rinsho Byori. Japanese Journal of Clinical Pathology 51(1): 13-18
George, E.; Kamarulzaman, E. 1979: Prognostic significance of morphological and cytochemical markers in adult acute myelogenous leukaemia: concepts and observations Medical Journal of Malaysia 34(2): 184-186
Kuryliszyn-Moskal, A.; Klimiuk, P.Adrian.; Ciolkiewicz, M.; Sierakowski, S. 2008: Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus Journal of Rheumatology 35(7): 1307-1313
Tan, C.-W.; Liu, C.-T.; Wu, Y.-H. 2009: The clinical significance of noninvasive inflammatory markers in exhaled breath condensate and induced sputum in persistent asthmatic patients Zhonghua Nei Ke Za Zhi 48(4): 299-303
Schumacher, G.E. 1981: Pharmacokinetic concepts and applications affecting the clinical laboratory: I. General concepts and applications American Journal of Medical Technology 47(3): 157-161
Kobayashi, Y.; Tokue, A. 1998: Clinical usefulness of blood PICP, PINP and ICTP concentrations as bone metastasis markers in prostate cancer patients Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 2072-2076
Chevallier, M.; Chevallier-Lugon, Cé.; Pernin, T. 2019: The general practitioner : an essential actor to ensure a specific management in oncologic patients Revue Medicale Suisse 15(654): 1188-1192
Osminin, S.V.; Vetshev, F.P.; Rudenko, V.V.; Zaletaev, D.V.; Khorobrykh, T.V.; Nemtsova, M.V. 2016: The molecular genetic alterations in mucosa of intestines as markers of oncologic progression and estimate of effectiveness of anti-reflux operations in patients with Barrett's esophagus Klinicheskaia Laboratornaia Diagnostika 61(10): 681-685
Kuroda, I.; Ueno, M. 2009: Biochemical markers of bone turnover. new aspect. Bone metabolic markers in prostatic carcinoma Clinical Calcium 19(8): 1170-1177
Aleksandrova, I.N.; Koshkarova, I.V.; Lyshchev, A.A.; Sitskaia, K.O.; Zubarovskaia, L.S.; Akimova, S.L.; Shabanova, L.N.; Pluzhnikova, G.F.; Rudenko, V.I.; Khanson, K.P.; Afanas'ev, B.V. 1996: PCR-detection of cytomegalovirus infection in oncologic and non-oncologic patients with organ and tissue transplantation Voprosy Onkologii 42(5): 22-25
Hadj Taieb, S.; Kallel, L.; Feki, M.; Hammami, M.B.; Boubaker, J.; Hsairi, M.; Filali, A.; Kaabachi, N. 2013: Unbalanced bone remodeling in Tunisian patients with inflammatory bowel diseases La Tunisie Medicale 91(4): 273-277